Annual report pursuant to Section 13 and 15(d)

Schedule of Deferred Tax Assets and Liabilities (Details)

v3.23.1
Schedule of Deferred Tax Assets and Liabilities (Details) - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Income Tax Disclosure [Abstract]    
Net operating loss carryforwards $ 21,368 $ 19,993
Compensation 474 846
Research and development tax credits 2,710 2,423
Capitalized and Research Expenditures 2,595
Other 487 466
Total deferred tax assets 27,633 23,728
Property and equipment (27) (21)
Other (60) (105)
Total deferred tax liabilities (87) (126)
Total deferred taxes, net 27,546 23,602
Valuation allowance (27,546) (23,602)
Deferred tax liability, net